title: Sunitinib-induced pseudoporphyria.
authors.affiliation: Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain.
authors.forename: V
authors.initials: V
authors.lastname: Sanz-Motilva
authors.affiliation: Department of Dermatology, Hospital de Manises, Valencia, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Martorell-Calatayud
authors.affiliation: Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain.
authors.forename: B
authors.initials: B
authors.lastname: Llombart
authors.affiliation: Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain.
authors.forename: C
authors.initials: C
authors.lastname: Requena
authors.affiliation: Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain.
authors.forename: C
authors.initials: C
authors.lastname: Serra-Guillén
authors.affiliation: Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain.
authors.forename: E
authors.initials: E
authors.lastname: Nagore
authors.affiliation: Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain.
authors.forename: C
authors.initials: C
authors.lastname: Guillén
authors.affiliation: Department of Pathology, Instituto Valenciano de Oncología, Valencia, Spain.
authors.forename: V
authors.initials: V
authors.lastname: Traves
authors.affiliation: Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain.
authors.forename: O
authors.initials: O
authors.lastname: Sanmartín
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001706:Biopsy; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis*; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011164:Porphyrias / Q000139:chemically induced* / Q000175:diagnosis; D011758:Pyrroles / Q000009:adverse effects* / Q000627:therapeutic use; D000077210:Sunitinib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib